Wednesday, July 8, 2026

biotech · Head and Neck Cancer · Solid Tumor · PPBT

PURPLE BIOTECH

PURPLE BIOTECH patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

REHOVOT, L3, USA HQ
2010 Founded
12 Employees
Public company Type
PPBT · NYSE Ticker
Company details
Status
Public
HQ
REHOVOT, L3, USA
Founded
2010
Employees
12
Programs
3
Drugs
4
Patents
3
Intelligence · Patents

PURPLE BIOTECH patents

3 pharmaceutical patents indexed for PURPLE BIOTECH. 0 expire within 24 months.

PURPLE BIOTECH has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12378277

    SGLTS/DPP4 inhibitor and application thereof

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11752184

    Bioactive concentrates and uses thereof

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11484523

    Compositions for prevention and treatment of symptoms associated with alcohol consumption

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does PURPLE BIOTECH have?

3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do PURPLE BIOTECH patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.